Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
yes - I think they have misplaced the "ticker" ... annoying but google seems to do that to MTR every now and again. Can sell at 22.875p currently!!
thanks ... I'm happy to sit tight on this one then as (1) it builds to the application decision (2) more people notice it/ remember the assets it holds .
I doubt we will hear that much on the Auz / NZ trials as mgt are not the most talkative but a good update could push the sp up in the meantime
Either way happy to hold
I don't know whether Frank and Betty were up early this morning but I tried doubling up and couldn't get a confirmed price ... in the end tried trades right down to 50k shares and each time it went to negotiated ...
Hi , haven't been in mnrg for a bit ... looked again this week and taken a position as looks undervalued IMO. Is there any more detail / commentary on "Frank and Betty" outside of the RNS? Thanks
Hi 28jaczar,
so i haven't been in OVB for a bit but looks like it's good value again .. people seem to regularly forget the assets its holds when the news flow is quiet (OVB's POLY shares up 7% today). Having said that can you confirm that I read the 5th January announcement right that the application was resubmitted for the Russian Market in January with decisions by September/October? Also it looks like investors have missed Friday's news the next wave of trials is starting in Australia (in preparation for an application to use in Western markets).
Feels like a bargain at under 10p
It's a long upwards road ahead
thanks Eva1989 ... feels right time to get back in ... might have a little dip but mid-term is good
Hi Eva1989 ... haven’t been in HOC for a while but has always been a good share for me. Watching from the side it looks like it’s bottoming out to me and a good time to enter - do you agree?
Sad day with the sale of DT Ultravert … the great hope that got me to invest originally. I'm with you Leemuu that there is potential in the pharma play and hence am sticking with Zoetic.
Did any one else notice the 400k shares that went through at the close … they showed up on London Stock Exchange (but not on trades list here) ?
Good RNS on the imminent share buy back … nice concept if its part funded by div's from Sunfire. My read of the RNS was that there was also cash and poss sale of assets, eg Sunfire shares to fund the buy back.
Either way, having just exited SPD after a lucrative share buy back (2 tranches took it from £2 to £3 in past few months) I have topped up my holding here as I see the same potential for a buy back to address the current discounted market cap. I cant see it making the 2.5p of the Director's Interview but I am hoping to get over 1.8 from where we are
So it's made £3 … 11 days before the closed period so unlikely to get a new share buy back tranche at £3.50 or £4 before 25th Oct ... closed period through to December interims (was 13th Dec last year) ... hence am guessing we will have a couple of months of flatlining
I'm not sure he ever stood much chance on the court case with the level of landlord support unfortunately.
On Cambridgeblue's question - MA is on about 62% of the company but each buy back is relatively small 10m shares=c.0.2%. I don't think he is trying to take the company private - it makes his assets illiquid and stops his opportunity to make a profit from trading shares. If you look at his track record over recent years then there is a pattern that could be explained as: bad news (inc negative PR) dropping the share price … then a period of 2or3 share buy backs (using up the strong cash flow from the business) getting the share price up (often coupled with better news from the company) … and then MA selling £100m or £200m worth of shares at the higher share price. Net Net he ends up with the same % but has received £100-200m pre-tax in effect using company cash flow of only £60-100m that if it had been dividend'ed out then he would of only got his 62% share pre-tax. Watching his share buy backs over the last 5 years has been interesting
Indeed … announced another 10m shares up to £3/share after the AGM … runs through to 25th Oct closed period but could get to £3 price cap before that. In previous years, when that happens, they have sometimes announced an additional buy back up to a higher price. I'm not sure what appetite there is for the share without a buy back
Its not a smooth ride but 214p to 248p since the latest share buy back started on 29th July. It's max 10m shares up to £3 and finishes on 10th September. Feels like it will keep climbing till 10th … could get another nice 20% rise in by then from Friday's close. Day traders paradise.
Thanks ReoninV, much appreciate the feedback and assessment … refreshing honesty compared with many other boards.
I am looking at renewable technology businesses and new to AFC … can any LTH's give me a head up to how the company has performed and what its opportunities are? Thanks
I don’t post often despite being a long term/suffering holder of ovb/ovb so as keen as anybody for the sp to reflect the underlying assets (poly shares, cash, and operations) but let’s stick to facts on this board and then nobody will lose sleep over penniless pensioners
I agree that the brief 7am rns was laughable in terms of the 2018/2019 typo and its brevity. However reading the later RNS and spending some time researching then there is a lot to the company and technology they are investing in, eg from http://www.publicnow.com/view/3926AD367E0B34591AF0EC78CC6E39BEDF74278D) .
I agree with your concerns about management historically - they haven't exactly been busy in the last 4 years however the results back in May and RNS again today have some of mgt leaving and the statement that more will go.
Thus I see this as the changing of the business from a cash shell (former miner) into a biotech/pharma business … clearly a big shift and I can imagine a bunch of investors will exit but the bios for the new management and their proven track record in pharma has me staying in (and hopefully getting the upside of a special div from the surplus cash/assets and sale of the gold asset … don't forget the market cap is still way under asset value even after the $6m investment)
the summary that they have published (http://www.publicnow.com/view/3926AD367E0B34591AF0EC78CC6E39BEDF74278D) includes a lot of interesting information - eg IVIX has had over $6m investment to date … despite the very brief RNS first thing (and the 2019 typo) there is a lot to this acquisition and we have a new strategic direction. The new board directors are impressive. Biotech wont be for everyone but I can see this now getting back to asset value (Poly shares and remaining cash) before moving beyond reflecting IVIX
http://www.nationmultimedia.com/news/Startup_and_IT/30318025
There is a fair bit more info on line now in connection with the new non-execs that have been announced. Eg one of theme is the creator and mentor to the IVIX product